- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Bladder Urothelial Carcinoma
Total 25679 results
-
Astellas Pharma IncSeagen Inc.CompletedMetastatic Urothelial CancerJapan
-
Mabwell (Shanghai) Bioscience Co., Ltd.Not yet recruitingAdvanced Urothelial CarcinomaChina
-
Sheba Medical CenterRecruiting
-
CHU de Quebec-Universite LavalCancer Research SocietyWithdrawnMetastatic Urothelial CarcinomaCanada
-
Fondazione IRCCS Istituto Nazionale dei Tumori,...CompletedMetastatic Urothelial CarcinomaItaly
-
Lee's Pharmaceutical LimitedActive, not recruitingAdvanced Urothelial CarcinomaChina
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedRenal Pelvis and Ureter Urothelial CarcinomaUnited States
-
Spanish Oncology Genito-Urinary GroupRoche Pharma AGCompletedLocally Advanced or Metastatic Urothelial CarcinomaSpain
-
Xiangya Hospital of Central South UniversityHunan Cancer Hospital; The Third Xiangya Hospital of Central South University; Hunan Provincial People's Hospital and other collaboratorsCompletedHigh-Grade Upper Tract Urothelial CarcinomaChina
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityRecruitingMetastatic Urothelial CarcinomaChina
-
University of Michigan Rogel Cancer CenterCelgene CorporationTerminatedBladder Cancer | Urothelial CancerUnited States
-
University of California, DavisNational Cancer Institute (NCI); IO BiotechRecruitingStage 0a Bladder Cancer AJCC v8 | Stage 0is Bladder Cancer AJCC v8 | Stage I Bladder Cancer AJCC v8 | High Risk Non-Muscle Invasive Bladder Urothelial CarcinomaUnited States
-
AnchorDx Medical Co., Ltd.Peking University First Hospital; Peking Union Medical College Hospital; Peking... and other collaboratorsRecruitingUpper Tract Urothelial CarcinomaChina
-
Memorial Sloan Kettering Cancer CenterActive, not recruitingUpper Tract Urothelial CarcinomaUnited States
-
RenJi HospitalUnknown
-
Jonsson Comprehensive Cancer CenterUroGen Pharma Ltd.No longer availableUrothelial Carcinoma Ureteral LocationUnited States
-
Shandong New Time Pharmaceutical Co., LTDUnknownLocally Advanced or Metastatic Urothelial Cell Carcinoma
-
Astellas Pharma Global Development, Inc.Seagen Inc.Approved for marketingLocally Advanced or Metastatic Urothelial Carcinoma (UC)United States
-
Janssen Research & Development, LLCRecruitingUrinary Bladder NeoplasmsUnited States, Korea, Republic of, France, Israel, Spain, Italy, United Kingdom, Belgium, Germany, Netherlands
-
Taiho Oncology, Inc.Merck Sharp & Dohme LLCActive, not recruitingAdvanced and Metastatic Urothelial CancerSpain, United States, France
-
Abdelwahab HashemUnknownTrauma | Bladder Cancer | Injuries | Bladder Urothelial Carcinoma | Perforation of Bladder | Recurrence Tumor | Resection Margin | Seeding, NeoplasmEgypt
-
BeiGeneCompletedLocally Advanced or Metastatic Urothelial Bladder CancerKorea, Republic of, China
-
National Cancer Institute (NCI)TerminatedUrothelial CancerUnited States
-
Principia Biopharma, a Sanofi CompanyTerminatedSolid Tumors | Metastatic Urothelial Carcinoma & Renal Pelvis & UreterSpain, United States
-
RenJi HospitalXiangya Hospital of Central South University; Shanghai Zhongshan Hospital; West... and other collaboratorsRecruitingUpper Tract Urothelial Carcinoma Receiving Kidney-sparing TherapyChina
-
University of Michigan Rogel Cancer CenterGlaxoSmithKlineWithdrawnBladder Cancer | Urothelial CancerUnited States
-
Bristol-Myers SquibbOno Pharmaceutical Co. LtdRecruitingUrinary Bladder NeoplasmsUnited States
-
Incyte CorporationCompletedUC (Urothelial Cancer)United States, Netherlands, Spain, Denmark, Belgium, Israel, Italy, Germany, France, Japan, United Kingdom
-
Jonsson Comprehensive Cancer CenterMerck Sharp & Dohme LLC; Seagen Inc.Not yet recruitingRenal Pelvis and Ureter Urothelial CarcinomaUnited States
-
Centre Hospitalier Universitaire de NīmesINSERM U1194, Institut de Recherche en Cancérologie de Montpellier, Campus...RecruitingTumor | Xenograft Model | Upper Urinary Tract Urothelial Carcinoma | NephroureterectomyFrance
-
Incyte CorporationMerck Sharp & Dohme LLCCompletedUC (Urothelial Cancer)United States, France, Belgium, Israel, Spain, United Kingdom, Korea, Republic of, Taiwan, Australia, Netherlands, Japan, Germany, Ukraine, Canada, Ireland, Italy, Poland, Russian Federation
-
Pacific Edge LimitedRecruitingUrothelial Bladder CancerUnited States
-
G1 Therapeutics, Inc.TerminatedBladder Cancer | Urothelial Carcinoma | Chemotherapy-induced Neutropenia | Myelosuppression Adult | Metastatic Bladder CancerHungary, Spain, United States, France, Georgia
-
Merck Sharp & Dohme LLCCompletedUrothelial Carcinoma Associated 1 RNA, Human
-
AHS Cancer Control AlbertaPfizerCompletedBladder Cancer | Urothelial Cancer | AdultCanada
-
H. Lee Moffitt Cancer Center and Research InstituteBristol-Myers Squibb; Gilead SciencesActive, not recruitingMetastatic Urothelial CarcinomaUnited States
-
Acerta Pharma BVMerck Sharp & Dohme LLCCompletedMetastatic Urothelial CarcinomaUnited States
-
Dr Anders UllénCompletedBladder Cancer | Urothelial Carcinoma | Urethra Cancer | Ureter Cancer | Renal Pelvis CancerDenmark, Sweden
-
Rain Oncology IncWithdrawnMilademetan in Combination With Atezolizumab in Patients With Advanced Solid Tumors With CDKN2A LossMelanoma | Renal Cell Carcinoma | Gastric Cancer | NSCLC | Mesothelioma | Advanced Solid Tumor | Pancreas Adenocarcinoma | Urothelial Carcinoma Bladder | HNSCC | CDKN2A
-
TJ Biopharma Co., Ltd.WithdrawnFirst-line Non-small-cell Lung Cancer | First-line Urothelial Carcinoma | Second-line Urothelial Carcinoma | Second-line MelanomaChina
-
University of Southern CaliforniaNational Cancer Institute (NCI)WithdrawnStage II Bladder Urothelial Carcinoma
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, Germany; Gilead Sciences; Nektar TherapeuticsRecruitingLocally Advanced or Metastatic Urothelial CarcinomaKorea, Republic of, United States, Taiwan, Australia, United Kingdom, France, Greece, Italy, Belgium, Spain, Canada, Denmark, Germany
-
Incyte CorporationMerck Sharp & Dohme LLCCompletedUC (Urothelial Cancer)United States, Spain, Hungary, Israel, United Kingdom, Korea, Republic of, Taiwan, Denmark, France, Netherlands, Italy, Canada, Japan, Turkey, Germany, Ireland, Australia, Russian Federation
-
Prof. Dr. Thomas OttoCompletedAdvanced Urothelial Cancer of Bladder After Failure of Platinum-containing Therapy.Germany
-
University of MichiganCompletedUrinary Tract Urothelial CarcinomaUnited States
-
The Methodist Hospital Research InstituteActive, not recruitingNon-Small Cell Lung Cancer | DNA Repair-Deficiency Disorders | Head and Neck Squamous Cell Carcinoma | Urothelial Carcinoma Bladder | Classical Hodgkin Lymphoma | Malignant MelanomaUnited States
-
University of Alabama at BirminghamBayer Healthcare Pharmaceuticals, Inc./Bayer Schering PharmaCompletedUrothelial Cancer (Urinary Bladder, Ureters, or Renal Pelvis Cancer)United States
-
University of Texas Southwestern Medical CenterRecruitingSmoking Cessation | Bladder Cancer | Urothelial Carcinoma | HematuriaUnited States
-
Flare Therapeutics Inc.RecruitingAdvanced Solid Tumors Cancer | Advanced Urothelial Carcinoma | Open Label | Oral Drug AdministrationUnited States
-
Medical Enterprises Ltd.TerminatedUrinary Bladder Cancer | Bladder Cancer | Malignant Tumor of Urinary Bladder | Bladder Neoplasm | Cancer of Bladder | Carcinoma in Situ of Bladder | Bladder Tumors | Cancer of the Bladder | Neoplasms, Bladder | Papillary Carcinoma of Bladder (Diagnosis) | BCG-Unresponsive Bladder CancerUnited States